Full Text
HIGH COURT OF DELHI
CS(COMM) 592/2023 & I.A. 16219/2023
MEDICOVER HOLDING (CYPRUS) LIMITED & ORS. ..... Plaintiffs
Through: Mr. Pravin Anand, Ms. Tusha Malhotra and Ms. Yamini Jaswal, Advs.
Through: None
JUDGMENT
26.09.2023
1. Keeping in mind para 8 of the order passed by the Division Bench of this Court in Dabur India Ltd. v. Emami Ltd.1, I had, while issuing summons in the present suit on 28 August 2023, demurred from passing any injunctive orders in the present application, preferred by the plaintiff under Order XXXIX Rules 1 and 2 of the Code of Civil Procedure 1908 (CPC), and had, instead, issued notice on the application so that the defendants would have an opportunity to respond. Order dated 21 August 2023 in FAO(OS) (COMM) 171/2023
2. There was no appearance from the defendants on the last date of hearing i.e., 21 September 2023, though the defendants stood served by e-mail and WhatsApp.
3. In order to do complete justice, I had directed fresh service on the defendants by courier through Blue Dart. The service has been effected. An affidavit of service has been placed on record along with a tracking report of the Blue Dart agency, which shows that delivery of the papers relating to the present case on the date has also taken place.
4. Despite this, there is no appearance on behalf of the defendants. As already noted, there is no response, either, to the present application whereby the plaintiffs seek interlocutory injunctive relief.
5. In the circumstances, I have heard Mr. Pravin Anand, learned Counsel for the plaintiff and perused the material on record.
6. The Plaintiff 1 is a company incorporated under the laws of Cyprus in 2006 and is a member of the Medicover group of companies. The Medicover group is stated to have two entities in India, namely, Plaintiff 2 Medicover Healthcare Private Limited and Plaintiff 3 Sahrudaya Health Care Private Limited.
7. Plaintiff 3 operates a hospital and Plaintiff 2 operates medical clinics. Plaintiff 1 conducts its business activities through Plaintiffs 2 and 3.
8. Plaintiff 1 is the registered proprietor of the following marks across country: Registration No. Mark Application Date Class User Claim 4232337 11/07/2019 35,36, 39,42, 43,44 01/01/2016 4232338 11/07/2019 35,36, 39,42, 43,44 3151491 MEDICOVER 05/01/2016 36,44 3151491 3151492 05/01/2016 36,44 3151492 4205553 13/06/2019 36,42, 4205554 13/06/2019 36,42, 4205555 13/06/2019 36,42, 4205556 13/06/2019 36,42, 4205504 13/06/2019 36,42, 4205505 13/06/2019 36,42, 4205506 13/06/2019 36,42, 4199151 06/06/2019 36,42,
9. License to use the aforesaid marks has been granted by Plaintiff 1 to Plaintiffs 2 and 3. The licence agreement has also been placed on record.
10. Under the aforesaid marks, the Medicover Group provides a broad spectrum of healthcare services, through an extensive network of ambulatory clinics, hospitals, specialty care facilities and laboratory. The plaintiffs are also operating fertility clinics.
11. Apropos the services rendered by the plaintiffs, the plaint avers that the services may be distributed into three categories, namely, healthcare services, diagnostic services and fertility services.
12. The plaintiffs claim to be offering high-quality healthcare based on an integrated healthcare model and fee-for-service. Towards that end, the plaintiffs operate 175 medical clinics, 41 hospitals, 107 dental clinics, 28 fertility clinics, 38 optic showrooms, 15 mental-health centers, 49 pharmacies and 126 gyms. Diagnostic services are provided by the plaintiff through a broad range of laboratory testing in all major clinical pathology areas. Plaintiffs conducts its business through a network of 104 laboratories, including 876 blood-drawing points (BDPs) and 27 clinics. India is, according to the plaint, one of the largest markets for providing of diagnostic services by the plaintiffs. The plaintiffs also provide fertility services in more than 22 countries including IVF, IUI, ICSI and other associated services.
13. In India, it is stated that the Medicover group operates over 24 Medicover hospitals in Telengana, Andhra Pradesh and Maharashtra, which provide for over 5500 beds. They claim to have served around 3.[9] lakhs patients over the last five years. The Medicover hospital has also been awarded the “Best Multispecialty Hospital of the Year” at the Indian Leadership Awards in New Delhi in 2020.
14. The plaintiff also maintains inter-active websites at https://www.medicoverfertility.in/ivf-centre, https://www.medicover. com/ and https://www.medicoverhospitals.in/.
15. In order to vouchsafe its reach and reputation, the plaintiffs have also provided their annual sales turnover from the year 2016 to 2022, through the use of the brand Medicover in India. In 2021 and 2022 alone, the turnover is ₹ 9,487,866,658/- and ₹ 10,342,810,015/respectively.
16. The plaintiff is aggrieved by the fact that Defendant 1 hospital, which is operated by Defendant 2, is using a mark which is identical to that of the plaintiff. The two marks may be thus viewed side-byside: Plaintiffs’ mark Defendant’s mark
17. At a bare glance, it is apparent that the defendant has copied the mark of the plaintiffs, the only difference being that the colour and background is different with the defendant’s background being of a lilac purple whereas the plaintiffs’ is blue.
18. In these circumstances, the plaintiff issued a cease and desist notice to the defendant on 18 April 2023, calling on the defendant not to use the impugned mark. This was followed up by a subsequent communication dated 28 May 2023. Neither of these communications has elicited any response.
19. The defendant 1 hospital is situated in UP and the defendants are using the mark MEDICOVER as well as the impugned logo in the State and also advertising its services on flyers and hoardings. Photographs of such advertisements have also been placed on record.
20. The plaintiff has also provided a tabular comparison of the rival marks thus:
1. Word mark MEDICOVER MEDICOVER
2. Logo/Device Mark • The figure of a man with a stylized arch over its head in white color on a blue background. • The word MEDICOVER in a white font on a blue • The figure of a man with a stylized arch over its head in white color on a red background. white font on a red background right underneath the device of the man.
21. The defendants have not chosen to enter appearance in this matter despite having been served by e-mail, WhatsApp and courier, and despite the matter having been listed twice after issuance of notice on this application.
22. In such circumstances, for the purposes of the present application, the assertions in the plaint have to be treated, prima facie, as correct on the basis of the principle of non-traverse.
23. Mr. Pravin Anand submits that this is a clear case of infringement, inasmuch as the rival marks are identical. The services provided by the plaintiffs and the defendants are also the same, as they cater to the same customer segment, i.e., patients looking for therapeutic facilities. As such, the triple identity test, which is required to be satisfied for infringement, is also satisfied.
24. I find considerable merit in these submissions. Even otherwise, a bare glance at the logo of the defendant reveals that it has copied all essential features of the plaintiffs’ logo. The plaintiffs are clearly unique as certain specific features such as a picture of a man with a stylized arch over his head in white colour. This is a feature unique to the plaintiffs’ mark which has been replicated identically in the mark of the defendant. The words “MEDICOVER HOSPITAL” as written below the defendant’s logo, is also written in a fashion similar to the manner in which it is written by the plaintiffs.
25. The word “MEDICOVER” is also indelibly associated with the plaintiffs. It is a word which has no independent etymological connotation. It is, therefore, a coined word which is entitled, even for that reason, to additional trade mark protection.
26. A customer of average intelligence and imperfect recollection, who comes across these two logos at two different points of time, is bound to believe them to be relating to the same entity. Besides, the manner in which the logo has been imitated, reveals a transparent intent on the part of the defendant to misrepresent itself as a hospital run by the plaintiffs.
27. The manner in which the defendants have replicated the figure of man with the arch above his head and the the word “MEDICOVER HOSPITAL” below its mark, reveals a transparent intent to misrepresent itself as a hospital run by the plaintiffs.
28. Mr. Anand also seeks to submit that the defendant has been found guilty of malpractice. Defendant 1 is one of the hospitals which has been excluded/de-listed by the Aditya Birla Health Insurance Co. Ltd.
29. In view of the aforesaid, the case being one of transparent infringement as well as passing off, and the defendant having demurred from from filing any response despite being put on notice regarding the present matter, the assertions in the plaint have to be treated as admitted. Even otherwise, a bare glance at the rival marks reveals the case to be one of prima facie infringement and passing off.
30. In such a case, the Supreme Court has, in the following passages from Laxmikant V. Patel v. Chetanbhai Shah[2] and Midas Hygiene Industries P. Ltd. v. Sudhir Bhatia[3], has directed that ordinarily an ex-parte ad interim injunction is required to be granted: Laxmikant V. Patel[2]
31. In the present case, despite issuance of notice, there is no appearance on behalf of the defendants. The plaintiff is, therefore, entitled to an injunction as sought. As such, pending disposal of the suit, the defendants as well as all others acting on its behalf shall stand restrained from selling, offering for sale, advertising, directly or indirectly dealing in any manner with services under the mark MEDICOVER or the logo or using any trade mark or logo which is identical or deceptively similar to the plaintiff’s registered “'MEDICOVER”,,, marks.
32. IA 16219/2023 stands allowed accordingly.
C. HARI SHANKAR, J.
SEPTEMBER 26, 2023